Terragen Holdings Ltd (TGH) AI Stock Analysis

• Market Cap: AU$9.60M
• Dividend Yield: N/A
• Average Volume (3M): 238.12K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.01
• Revenue Growth: -26.94%
• EPS Growth: -4.08%
• Country: AU
• Employees: N/A
• Sector: Basic Materials
• Sector Strength: 71
• Industry: Agricultural Inputs
• EPS (TTM): >-0.01
• Shares Outstanding: 505,017,180
• 10 Day Avg. Volume: 477,022
• 30 Day Avg. Volume: 238,117
• PEG Ratio: -0.21
• Price to Book (P/B): 1.84
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -7.54
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 40 Underperform
• Price Target: AU$0.00 ▼(-100.00%Downside)

The overall stock score reflects significant financial challenges with declining revenues and negative cash flows, combined with bearish technical indicators and poor valuation metrics. The absence of earnings call details and corporate events leaves these areas without influence.

Terragen Holdings Ltd Business Overview & Revenue Model

Company Description

Terragen Holdings Limited engages in the research, development, production, and sale of biological products for agriculture sector in Australia and New Zealand. It offers Mylo, an animal feed supplement; and Great Land, a liquid biological soil conditioner that improves soil characteristics. The company was incorporated in 1996 and is based in Coolum Beach, Australia.

How the Company Makes Money

Terragen Holdings Ltd generates revenue through the sale of its sustainable agricultural products, including bio-fertilizers and soil conditioners. The company targets both large-scale agricultural enterprises and smallholder farmers, providing products that improve crop yields and soil vitality. TGH may also engage in strategic partnerships with agricultural cooperatives and government agencies to expand its market reach. Revenue streams are further supported by research and development initiatives that lead to new product innovations and potential patent licensing agreements.

Terragen Holdings Ltd Financial Statement Overview

Summary

Terragen Holdings Ltd faces significant challenges with declining revenues, persistent losses, and operational inefficiencies impacting its income statement. Despite a strong equity position on the balance sheet, the continuous negative cash flows present a risk to sustainability.

Income Statement

Terragen Holdings Ltd has seen declining revenue from previous periods, with a TTM revenue of $1.85M compared to $2.14M annually. The gross profit margin is strong at 74.15% for TTM, yet EBIT and EBITDA margins are negative, indicating operational inefficiencies. The company faces consistent net losses, affecting the net profit margin negatively.

Balance Sheet

The company's balance sheet shows a strong equity position with an equity ratio of 74.83% in TTM, which indicates financial stability and lower leverage. However, the debt-to-equity ratio is low at 0.08, suggesting low usage of debt financing. The high stockholders' equity offers a cushion against liabilities.

Cash Flow

Terragen Holdings Ltd has a concerning cash flow position, with negative operating and free cash flows, indicating cash outflows exceeding inflows. The operating cash flow to net income ratio is negative, highlighting inefficient cash generation from operations. The free cash flow growth rate is also negative, reflecting ongoing cash burn.

Breakdown	TTM	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020
Income Statement
Total Revenue	1.85M	2.14M	3.28M	2.89M	3.65M	1.53M
Gross Profit	1.37M	2.06M	3.21M	2.62M	3.19M	1.09M
EBITDA	-5.64M	-3.50M	-3.46M	-5.67M	-6.13M	-4.97M
Net Income	-3.82M	-3.01M	-3.23M	-5.41M	-6.10M	-4.93M
Balance Sheet
Total Assets	8.24M	6.95M	6.35M	9.22M	14.72M	18.97M
Cash, Cash Equivalents and Short-Term Investments	6.09M	4.54M	4.17M	6.67M	11.64M	16.38M
Total Debt	521.92K	542.23K	239.37K	332.26K	357.96K	476.31K
Total Liabilities	2.08M	1.63M	1.27M	1.46M	1.70M	1.92M
Stockholders Equity	6.17M	5.32M	5.08M	7.76M	13.02M	17.04M
Cash Flow
Free Cash Flow	-2.01M	-2.35M	-2.91M	-4.97M	-4.93M	-4.33M
Operating Cash Flow	-2.01M	-2.32M	-2.81M	-4.80M	-4.52M	-3.89M
Investing Cash Flow	-182.04K	-132.93K	-35.20K	-118.20K	-408.02K	-441.45K
Financing Cash Flow	2.50M	2.82M	351.00K	-52.70K	194.92K	18.88M

Terragen Holdings Ltd Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.02
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Positive
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:TGH, the sentiment is Negative. The current price of 0.02 is above the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.03, and below the 200-day MA of 0.03, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 11.17 is Positive, neither overbought nor oversold. The STOCH value of 74.60 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:TGH.

Terragen Holdings Ltd Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CDT	46 Neutral	AU$9.16M	―	-292.54%	―	―	63.44%
Sector *	44 Neutral	C$982.42M	-6.71	-13.24%	2.54%	17.20%	-32.72%
ABX	43 Neutral	AU$9.82M	―	-16.63%	―	-73.87%	-11.11%
RLF	43 Neutral	AU$15.99M	―	-93.06%	―	56.16%	-53.89%
TGH	40 Underperform	AU$9.60M	―	-58.72%	―	-26.94%	-4.08%
FTZZF		$10.24M	―	-16.68%	―	―	―
OLY	26 Underperform	AU$15.46M	―	-146.25%	―	―	-68.70%

Terragen Holdings Ltd Corporate Events

Terragen Secures US Patent for Microbial Feed Supplement

Terragen Holdings Limited has been granted a US patent for its microbial feed supplement, Terragen Probiotic for Ruminants™ and MYLO®, by the United States Patent and Trademark Office. This patent, valid until 2041, provides intellectual property protection in the US, a key market for Terragen, and supports the company’s efforts to secure regulatory approvals for product launch. The patent strengthens Terragen’s position in the global animal probiotics market, highlighting the innovative outcomes of its research and development program.

Terragen Holdings Announces CFO Resignation

Terragen Holdings Limited announced the resignation of its Chief Financial Officer and Company Secretary, Matthew Whyte, effective August 27, 2025, as he pursues other opportunities. The company is actively seeking his successor, and the transition is expected to impact its financial and administrative operations. The departure could influence Terragen’s strategic direction, given Whyte’s contributions to the company’s growth and development.

Terragen Expands Probiotic Offerings and Global Market Reach

Terragen Holdings Limited has launched new probiotic products for ruminants, supported by extensive marketing efforts, and is conducting trials to assess their effectiveness in methane mitigation and animal health. The company is expanding its market reach with trials in Canada and collaborations for global market access, aiming to enhance its industry positioning and unlock new commercial opportunities.